Healthcare & Life Sciences

09 June 2021

Would a TRIPS waiver improve access to COVID-19 vaccines?

A recent proposal calls for a waiver for all World Trade Organisation members of certain provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) in relation to the "prevention, containment or treatment" of COVID-19. However, without the voluntary cooperation of vaccine originator companies, a significant or rapid increase in the production of vaccines by third-party manufacturers is unlikely. This article discusses some of the limitations of the proposed TRIPS waiver.

Joanne van Harmelen Author: Joanne van Harmelen

International | ENSafrica

Read more

New leadership brings changes to health regulation

Alejandro Ernesto Svarch-Pérez was recently appointed as the new head of the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS), the Mexican regulatory agency. With the change of leadership, various new sources of information have become available for regulated companies and the public in general. These initiatives revive COFEPRIS's image and provide hope to regulated industries and life sciences lawyers.

Maria Luisa Mendoza Author: Maria Luisa Mendoza

Mexico | Sanchez DeVanny Eseverri SC

Read more

Recent updates

Court upholds validity of one pneumococcal vaccine patent but holds two others invalid

Lei Liu Author: Lei Liu

Canada | Smart & Biggar

Ins and outs of handling material non-public information

David Wardell Authors: David Wardell | Amy Greer | Carol Stubblefield

USA | Baker McKenzie

Creation of loco-regional hospital networks exempt from merger control rules

Beatrijs Gielen Authors: Beatrijs Gielen | Nina Methens

Belgium | ALTIUS

Review into R&D tax relief system – welcome development for life sciences sector?

Penny Simmons Author: Penny Simmons

United Kingdom | Pinsent Masons

Compulsory patent licence as defence against claim for preliminary injunction

Ludvig Holm Authors: Ludvig Holm | Måns Ullman

Sweden | Westerberg & Partners Advokatbyrå Ab

COVID-19 pandemic: relief for vaccination damage provided by law

Fabian Huber Authors: Fabian Huber | Caroline von Nussbaum

Germany | Simmons & Simmons LLP

Biosimilar regulation FAQs

Joanne van Harmelen Author: Joanne van Harmelen

South Africa | ENSafrica

Court dismisses complaint against limitations on sale of medicinal products

Rainer Herzig Author: Rainer Herzig

Austria | Preslmayr Attorneys at Law